Cargando…
Neurotensin analogs by fluoroglycosylation at N(ω)-carbamoylated arginines for PET imaging of NTS1-positive tumors
Since neurotensin (NT) receptors of subtype-1 (NTS1) are expressed by different types of malignant tumors, such as pancreatic adenocarcinoma, colorectal and prostate carcinoma, they represent an interesting target for tumor imaging by positron emission tomography (PET) and endoradiotherapy. Previous...
Autores principales: | Schindler, Lisa, Wohlfahrt, Katrin, Gluhacevic von Krüchten, Lara, Prante, Olaf, Keller, Max, Maschauer, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440028/ https://www.ncbi.nlm.nih.gov/pubmed/36056076 http://dx.doi.org/10.1038/s41598-022-19296-0 |
Ejemplares similares
-
Sweetening Pharmaceutical Radiochemistry by (18)F-Fluoroglycosylation: A Short Review
por: Maschauer, Simone, et al.
Publicado: (2014) -
Sweetening Pharmaceutical Radiochemistry by (18)F-Fluoroglycosylation: Recent Progress and Future Prospects
por: Shinde, Sandip S., et al.
Publicado: (2021) -
Thermostabilisation of the neurotensin receptor NTS1
por: Shibata, Yoko, et al.
Publicado: (2009) -
Ventral Midbrain NTS1 Receptors Mediate Conditioned Reward Induced by the Neurotensin Analog, D-Tyr[11]neurotensin
por: Rouibi, Khalil, et al.
Publicado: (2015) -
Insightful Backbone Modifications Preventing Proteolytic Degradation of Neurotensin Analogs Improve NTS1-Induced Protective Hypothermia
por: Previti, Santo, et al.
Publicado: (2020)